IDEXX posts lower Q1 earnings, cuts full-year outlook

IDEXX Laboratories Inc. (Nasdaq: IDXX), the Westbrook maker of veterinary diagnostics, veterinary software and water testing, on Wednesday posted lower first-quarter earnings than a year ago and cut its outlook for 2022 due to the strengthening U.S. dollar, higher interest rates and the war in Ukraine.

Quarterly earnings totaled $193.9 million, or $2.27 a share, down from $204.3 million, or $2.35 a share, for the same period in 2021. The results, while lower, still surpassed Wall Street expectations of $2.25 a share, according to Zacks Investment Research. Read more

Related Posts

Business Leaders: Deborah Bronk steers Bigelow Lab expansion to boost reach, programming

Deborah Bronk is president, CEO and a senior research scientist at Bigelow Laboratory for Ocean Sciences in East Boothbay, which will...

24 March 2025

UNE retains R2 Research status, reinforcing leadership in scientific advancement

The University of New England has retained its status as one of the country’s leading research universities with the recent release...

23 March 2025

Maine college students investigate health effects of forever chemicals

Two dozen Maine college students are investigating the public health effects of forever chemicals by using zebrafish as human stand-ins and...

21 March 2025